melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling
Melior Discovery

Our Services
High Throughput In Vivo Pharmacology:
Discovery Services:
Our Technology
         

theraTRACE

Melior Pharmaceuticals

Click here to download the Melior Brochure        

Click here to download the Melior Models list           

 

 
News from Melior  

Melior Pharmaceuticals Announces New Scientific Advisory Board Member Dr. John Amatruda, an Expert in the Field of Diabetes and Drug Development to Join Board

Melior Discovery Is Awarded Grant From Michael J. Fox Foundation

Melior Receives Patent Notice for Repositioned
Drug Candidate MLR-1023

Melior Discovery Strengthens Scientific Leadership Team with Addition of Dr. John Gruner


Melior Discovery is dedicated to uncovering new therapeutic applications for partners' existing drugs. By utilizing the unique and highly efficient theraTRACE® indications discovery platform, Melior can systematically study a single compound in multiple in vivo models, thereby evaluating potential utility in a variety of major therapeutic areas.



 

home theraTRACE Melior Pharmaceuticals